The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers

IMPACT Steering Committee

doi:10.1016/j.urolonc.2015.01.018

The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers

IMPACT Steering Committee

Research output: Contribution to journal › Article › Scientific › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	202e19-202e28
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	33
Issue number	5
DOIs	https://doi.org/10.1016/j.urolonc.2015.01.018
Publication status	Published - 2015
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

BRCA2
Diagnostic value
Marker
PCA3
PSA
Prostate cancer gene 3

Publication forum classification

Publication forum level 1

Access to Document

10.1016/j.urolonc.2015.01.018

Cite this

@article{5ac73197bffa455691f59b2bf20e19be,

title = "The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers",

keywords = "BRCA2, Diagnostic value, Marker, PCA3, PSA, Prostate cancer gene 3, BRCA2, Diagnostic value, Marker, PCA3, PSA, Prostate cancer gene 3",

author = "\{IMPACT Steering Committee\} and RG Cremers and Kiemeney, \{LA.Aaronson N\} and A Ardem-Jones and EK Bancroft and C Bangma and E Castro and D Dearnaley and D Eccles and RA Eeles and DG Evans and J Eyfjord and Hans Lilja and A Falconer and J Ringelberg-Borsboom and HF Vasen and \{Van Asperen\}, CJ and JA Schalken and GW Verhaegh",

year = "2015",

doi = "10.1016/j.urolonc.2015.01.018",

language = "English",

volume = "33",

pages = "202e19--202e28",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "5",

}

The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers. / IMPACT Steering Committee.
In: Urologic Oncology: Seminars and Original Investigations, Vol. 33, No. 5, 2015, p. 202e19-202e28.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers

AU - IMPACT Steering Committee

AU - Cremers, RG

AU - Kiemeney, LA.Aaronson N

AU - Ardem-Jones, A

AU - Bancroft, EK

AU - Bangma, C

AU - Castro, E

AU - Dearnaley, D

AU - Eccles, D

AU - Eeles, RA

AU - Evans, DG

AU - Eyfjord, J

AU - Lilja, Hans

AU - Falconer, A

AU - Ringelberg-Borsboom, J

AU - Vasen, HF

AU - Van Asperen, CJ

AU - Schalken, JA

AU - Verhaegh, GW

PY - 2015

Y1 - 2015

KW - BRCA2

KW - Diagnostic value

KW - Marker

KW - PCA3

KW - PSA

KW - Prostate cancer gene 3

KW - BRCA2

KW - Diagnostic value

KW - Marker

KW - PCA3

KW - PSA

KW - Prostate cancer gene 3

U2 - 10.1016/j.urolonc.2015.01.018

DO - 10.1016/j.urolonc.2015.01.018

M3 - Article

SN - 1078-1439

VL - 33

SP - 202e19-202e28

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 5

ER -